Singapore Neokidney Moves Closer

Nextkidney BV, which makes the sorbent-based home hemodialysis Neokidney, has signed a deal to buy Dialyss Pte. Ltd. as it gears up for commercialization. Next up: a clinical trial in Singapore, then a European multicenter trial, with CE mark submission in 2023.

Read the full article » | Posted 02-15-2022

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026